Skip to content
Mushroom Retreats

Psilocybin law in Connecticut

Illegal Checked 26 October 2026

Psilocybin is illegal in Connecticut: it is a Schedule I controlled substance under Conn. Agencies Regs. 21a-243-7, and possession is a class A misdemeanor, though a state pilot program provides psilocybin-assisted therapy through FDA-approved research.

Psilocybin is a controlled substance with no lawful route for retreats or personal use. Some of these states fund research or trials. A summary of published sources, not legal advice.

Source status: Research only. Psilocybin remains a Schedule I drug under US federal law.

Scheduling

Psilocybin and psilocyn are listed in Schedule I of the Connecticut controlled substance regulations, Regs. Conn. State Agencies 21a-243-7(c)(32) and (33). [Regulations of Connecticut State Agencies Sec. 21a-243-7, Controlled substances in schedule I, Connecticut eRegulations System (Department of Consumer Protection), 2026-05-13, read 26 October 2026]

What the law says

Penalties

Bills

  • SB 191 2026

    An Act Concerning the Psychedelic-Assisted Therapy Pilot Program

    Expands eligibility for the DMHAS psilocybin and MDMA therapy pilot to residents 18 and older and removes its automatic end on DEA approval.

    Status: Signed 4 June 2026 (Public Act 26-108), effective 1 July 2026, 4 June 2026

  • HB 7065 2025

    An Act Concerning the Decriminalization of Possession of Small Amounts of Psilocybin

    Would have decriminalized possession of small amounts of psilocybin.

    Status: Passed House 19 May 2025; placed on Senate calendar 20 May 2025; died at end of session, 20 May 2025

  • HB 5456 2025

    An Act Allowing the Use of Psilocybin for Medicinal and Therapeutic Purposes

    Would have allowed psilocybin use for medicinal and therapeutic purposes.

    Status: Referred to Public Health Committee 17 January 2025; died in committee, 17 January 2025

  • HB 6380 2025

    An Act Decriminalizing the Possession of Psilocybin

    Would have decriminalized possession of psilocybin.

    Status: Referred to Judiciary Committee 23 January 2025; died in committee, 23 January 2025

  • SB 855 2025

    An Act Concerning Funding for the Psychedelic-Assisted Therapy Pilot Program

    Would have appropriated funding for the psychedelic-assisted therapy pilot program.

    Status: Referred to Appropriations Committee 22 January 2025; died in committee, 22 January 2025

Dated changes

  • 4 June 2026: Expands eligibility for the DMHAS psilocybin and MDMA therapy pilot to residents 18 and older and removes its automatic end on DEA approval. Status: Signed 4 June 2026 (Public Act 26-108), effective 1 July 2026. Source
  • 20 May 2025: Would have decriminalized possession of small amounts of psilocybin. Status: Passed House 19 May 2025; placed on Senate calendar 20 May 2025; died at end of session. Source
  • 23 January 2025: Would have decriminalized possession of psilocybin. Status: Referred to Judiciary Committee 23 January 2025; died in committee. Source
  • 22 January 2025: Would have appropriated funding for the psychedelic-assisted therapy pilot program. Status: Referred to Appropriations Committee 22 January 2025; died in committee. Source
  • 17 January 2025: Would have allowed psilocybin use for medicinal and therapeutic purposes. Status: Referred to Public Health Committee 17 January 2025; died in committee. Source

The full law map, with 51 US entries and every country we cover, or every dated change.